danceriraq43
About
Apatinib for sufferers using metastatic biliary system carcinoma refractory to straightforward chemotherapy: results from a good investigator-initiated, open-label, single-arm, exploratory period Two review.
Apatinib for sufferers using metastatic biliary system carcinoma refractory to straightforward chemotherapy: results from a good investigator-initiated, open-label, single-arm, exploratory period Two review.